- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
NAG-NAG.1: 3 residues within 4Å:- Chain A: C.15, N.17, N.135
No protein-ligand interaction detected (PLIP)NAG-NAG.2: 4 residues within 4Å:- Chain A: N.120, T.122, K.127, Y.157
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 3 residues within 4Å:- Chain A: E.130, N.161, N.162
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 4 residues within 4Å:- Chain A: T.106, N.231, T.233
- Chain B: K.459
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 1 residues within 4Å:- Chain A: N.279
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 2 residues within 4Å:- Chain A: N.613, T.615
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 4 residues within 4Å:- Chain A: N.714, L.919, Q.923, Q.1068
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 3 residues within 4Å:- Chain A: N.798, S.800, Q.801
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 2 residues within 4Å:- Chain B: N.17, N.135
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 4 residues within 4Å:- Chain B: N.120, T.122, K.127, Y.157
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 3 residues within 4Å:- Chain B: E.130, N.161, N.162
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 4 residues within 4Å:- Chain B: T.106, N.231, T.233
- Chain C: K.459
No protein-ligand interaction detected (PLIP)NAG-NAG.16: 2 residues within 4Å:- Chain B: E.278, N.279
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 3 residues within 4Å:- Chain B: N.613, T.615, R.643
No protein-ligand interaction detected (PLIP)NAG-NAG.18: 3 residues within 4Å:- Chain B: N.714, L.919, Q.1068
No protein-ligand interaction detected (PLIP)NAG-NAG.19: 3 residues within 4Å:- Chain B: N.798, S.800, Q.801
No protein-ligand interaction detected (PLIP)NAG-NAG.23: 3 residues within 4Å:- Chain C: C.15, N.17, N.135
No protein-ligand interaction detected (PLIP)NAG-NAG.24: 4 residues within 4Å:- Chain C: N.120, T.122, K.127, Y.157
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:K.127
NAG-NAG.25: 3 residues within 4Å:- Chain C: E.130, N.161, N.162
No protein-ligand interaction detected (PLIP)NAG-NAG.26: 4 residues within 4Å:- Chain A: K.459
- Chain C: T.106, N.231, T.233
No protein-ligand interaction detected (PLIP)NAG-NAG.27: 2 residues within 4Å:- Chain C: E.278, N.279
No protein-ligand interaction detected (PLIP)NAG-NAG.28: 1 residues within 4Å:- Chain C: N.613
No protein-ligand interaction detected (PLIP)NAG-NAG.29: 4 residues within 4Å:- Chain C: N.714, L.919, Q.923, Q.1068
No protein-ligand interaction detected (PLIP)NAG-NAG.30: 3 residues within 4Å:- Chain C: N.798, S.800, Q.801
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.9: 3 residues within 4Å:- Chain A: A.703, E.1069, N.1071
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.20: 3 residues within 4Å:- Chain B: A.703, E.1069, N.1071
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.31: 4 residues within 4Å:- Chain C: A.703, E.1069, K.1070, N.1071
No protein-ligand interaction detected (PLIP)- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-MAN.10: 4 residues within 4Å:- Chain A: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.11: 1 residues within 4Å:- Chain A: N.1131
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.21: 4 residues within 4Å:- Chain B: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.22: 1 residues within 4Å:- Chain B: N.1131
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.32: 4 residues within 4Å:- Chain C: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.33: 1 residues within 4Å:- Chain C: N.1131
No protein-ligand interaction detected (PLIP)- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.34: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain A: Y.142, K.144, N.146
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain A: N.328, P.576, Q.577
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain A: N.340, S.368
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain A: N.600
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain A: N.654
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain A: N.706, G.1128
- Chain C: D.793
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain A: N.1155
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain B: Y.142, K.144, N.146
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: N.328, Q.577, T.578
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain B: N.340
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain B: N.600
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain B: N.654
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain A: D.793
- Chain B: N.706, G.1128
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain B: N.1155
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain C: K.144, N.146
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain C: N.328, P.576, Q.577
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain C: N.340
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.600
Ligand excluded by PLIPNAG.55: 1 residues within 4Å:- Chain C: N.654
Ligand excluded by PLIPNAG.56: 3 residues within 4Å:- Chain B: D.793
- Chain C: N.706, G.1128
Ligand excluded by PLIPNAG.57: 1 residues within 4Å:- Chain C: N.1155
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cai, Y. et al., Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Science (2021)
- Release Date
- 2021-07-07
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cai, Y. et al., Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Science (2021)
- Release Date
- 2021-07-07
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C